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This study evaluates the potential mechanism of action and bioactivity of black tea and
black tea pomace for type 2 diabetes prevention via inhibition of carbohydrate hydrolyz-
ing enzymes. Black tea leaves were extracted in hot water and black tea pomace was
extracted in 70% acetone. The phenolic content of the water extract (WBT) and pomace
acetone extracts (AOBT) were 5.77 and 8.9 mg/mL, respectively, both based on the same
concentration of solid tea in the extract.The water extract was subjected to C18 extraction
and the resulting hydrophobic fraction (HBBT) was further subjected to LH-20 extraction
to recover a low molecular weight phenolic enriched fraction (LMW) and a high mol-
ecular weight enriched fraction (HMW). The phenolic content of the LMW and HMW
fraction were 1.42 and 2.66 mg/mL, respectively. Among water extracts the HMW fraction
was most bioactive against α-glucosidase (IC50=8.97µg/mL) followed by HBBT frac-
tion (IC50=14.83µg/mL). However, the HBBT fraction was the most bioactive fraction
against α-amylase (IC50=0.049 mg/mL). The black tea pomace (AOBT) had significant α-
glucosidase inhibitory activity (IC50=14.72µg/mL) but lower α-amylase inhibitory activity
(IC50=0.21 mg/mL). The phenolic profiles for LMW and HMW fractions were evaluated
using HPLC and the differences between the two profiles were identified. Further research
is underway to identify and evaluate the phenolic compounds that are present in the HMW
fraction. Our findings suggest that black tea and black tea pomace has potential for carbo-
hydrate hydrolyzing enzyme inhibition and this activity depends on high molecular weight
phenolic compounds.
Keywords: α-glucosidase inhibition, black tea, black tea pomace, α-amylase inhibition, phenolic compounds, type
2 diabetes, pre-diabetes
INTRODUCTION
According to International Diabetes Federation (IDF) world-
wide 382 million people in 2013 had diabetes and this num-
ber is projected to increase to 592 million by 2035 (1). This
dramatic increase is mainly due to the increasing incidence
of type 2 diabetes (1), also called non-insulin-dependent dia-
betes, which is caused by the body’s ineffective use of insulin
(2). To prevent the increase of type 2 diabetes, Centers of Dis-
ease Control and Prevention (CDC) defined a state of bor-
derline type 2 diabetic patients, as pre-diabetes. The Amer-
ican Diabetes Association defines pre-diabetic individual as
an individual with blood glucose levels higher than normal
(impaired fasting glucose between 100 and 125 mg/dL, impaired
glucose tolerance between 140 and 199 mg/dL, and HbA1c
between 5.7 and 6.4%) but not high enough to be considered
Abbreviations: AOBT, acetone extract black tea; HBBT, hydrophobic fraction from
black tea water extract; HMW, high molecular phenolic-containing fraction (result-
ing from HBBT); HPBT, hydrophilic fraction from black tea water extract; LMW,
low molecular weight phenolic-containing fraction (resulting from HBBT); WBT,
water extract black tea.
diabetic (impaired fasting glucose between>126 mg/dL, impaired
glucose tolerance between >200 mg/dL, and HbA1c between
>6.5%) (3, 4).
Beside lifestyle change, which can prevent type 2 diabetes
there are also food-based active ingredients, such as polyphenols,
which have the ability to modulate blood glucose level (5). Recent
research has shown that phenolic compounds have the potential to
inhibit carbohydrate hydrolyzing enzymes in our digestive organs
and thus have potential to play a role in management of type 2
diabetes (6).
The major source of glucose in our body comes from the
hydrolysis of dietary carbohydrates, such as starch. The pan-
creatic alpha-amylase and intestinal alpha-glucosidases are the
hydrolyzing enzymes responsible for glucose generation via diet
(6). α-Amylase hydrolyzes alpha-1,4-glycocidic bonds and splits
up starch components such as amylose and amylopectin into
smaller oligosaccharides and disaccharides, like maltose. The α-
glucosidases hydrolyze disaccharides to monosaccharides. Previ-
ous reports suggest that the inhibition of these enzymes can be
an important concept for management of type 2 diabetes (7, 8).
Additional studies have shown that α-glucosidase inhibitors, such
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as acarbose, are the only oral anti-diabetes agent approved for the
treatment of pre-diabetes (9).
Tea is one of the most consumed beverages of the world. The tea
plant (Camellia sinensis) from which the beverage tea is processed
is a member of the genus Camellia and has over 200 species and
is originated in the highlands of Tibet, north eastern India, and
southern China. Today the major tea production countries are
India, China, Sri Lanka, Kenya, Japan, Vietnam, Bangladesh, and
Indonesia (10). Tea is generally consumed as green tea, oolong
tea, or black tea (11). This classification is according to degree of
fermentation: unfermented tea is green tea, semi-fermented tea is
oolong tea, and fully fermented tea is black tea (10). The different
process leads to unique characteristics, taste, and chemical pro-
file. Of these three types, black tea is most widely produced and
consumed, approximately 80%.
Polyphenols belong to phenolic phytochemicals and are sec-
ondary plant metabolites, widely distributed in plants. They are
known to be strong antioxidants and hence they are able to pre-
vent tissue damage caused by free radicals (10). The major phenolic
compounds present in green tea are flavonols, and more specifi-
cally catechins (10). Compared to green tea, the catechin content
in black tea is reduced by approximately 85% and transformed into
teaflavin-3-3′-digallate and thearubigin, which are catechin poly-
merization products (10). Previous research suggests that these
compounds can retard the absorption of glucose by inhibition of
carbohydrate hydrolyzing enzymes, such as α-glucosidase and α-
amylase in the digestive organs. Hence, α-glucosidase inhibitors
can retard the liberation of glucose from dietary complex carbo-
hydrates and delay glucose absorption, resulting in reduced post-
prandial plasma glucose levels and suppression of postprandial
hyperglycemia. This could be a good treatment for type 2 diabetes
prevention (12). Specifically for tea, Kwon et al. (6) reported that
green tea had the lowest α-glucosidase inhibitory activity, followed
by Oolong tea and black tea had the highest inhibitory activity.
These findings suggest that the observed α-glucosidase inhibitory
activity possibly depends on the catechin polymerization products
that are produced during fermentation.
In this study, we evaluate the potential mechanism and bioac-
tives of black tea and black tea pomace for type 2 diabetes preven-
tion via inhibition of carbohydrate hydrolyzing enzymes. More
specifically, we focus on the evaluation of black tea water extract
polyphenols and investigate if the observed bioactivity is low mole-
cular weight phenolic dependent (i.e., catechins) or high molecular
weight phenolic dependent (i.e., catechin polymerization prod-
ucts). Additionally, we extract the resulting pomace using acetone
and briefly evaluate its potential for carbohydrate hydrolyzing
enzyme inhibition. Completion of this study gives a better under-
standing of the possible effect and mechanism of black tea and
black tea pomace for possible prevention of type 2 diabetes.
MATERIALS AND METHODS
CHEMICAL/MATERIALS USED
The black tea used in our experiment (Lipton – Earl Grey bergamot
flavor) was purchased from a local supermarket (Stop and Shop,
Framingham, MA, USA). α-Glucosidase from Saccharomyces cere-
visiae (EC 3.2.1.20) as well as porcine pancreatic α-amylase (EC
3.2.1.1) were purchased from Sigma-Aldrich Co. (St. Louis, MO,
USA). Unless noted, all chemicals were also purchased from
Sigma-Aldrich Co. (St. Louis, MO, USA). All solvents used were
HPLC grade.
SAMPLE PREPARATION
Initially, 7.5 g tea leaves were extracted in 75 ml of distilled water
for 30 min at 90°C. After extraction the resulting sample was fil-
tered through a Whatman #54 to give the initial working sample
(WBT). WBT was stored at 4°C until further testing. The resulting
pomace was collected from the filter and was extracted in 70% ace-
tone. Briefly, leaves were dried in a drying oven at 100°C (AOBT).
After drying, 6 g of the dried leaves were extracted in 60 mL of a
70% acetone solution for 2 h at room temperature and under con-
stant stirring. The resulting extract was filtered using a Whatman
#54 filter and stored at 4°C until further testing.
C18 CARTRIDGE EXTRACTION
The water extract (20 mL of WBT) was subjected to solid phase
extraction using C18 cartridge (DSC-18, 3 mL Tube, 500 mg;
Supelco, Bellefonte, PA, USA). A subsample (500µL) of the
extract was loaded onto each pre-conditioned C18 (acetone fol-
lowed by distilled water) followed by rinsing with deionized water
to remove the hydrophilic compounds (HPBT). After washing,
the hydrophobic compounds (including phenolic compounds)
were eluted with 5 mL of 99:1 (v/v) methanol:acetic acid solu-
tion (HBBT). The solvent and water were evaporated from HBBT
and HPBT, respectively, using a rotary evaporator (Fisher Scien-
tific; Hanover Park, IL, USA) at 60°C to yield a final volume of
20 mL. The evaporated extract was stored at −4°C until further
testing.
LH-20 COLUMN EXTRACTION
The hydrophobic fraction (HBBT) was subjected to gel filtra-
tion chromatography using Sephadex LH-20 column extraction
to recover a high molecular weight fraction (HMW) and a low
molecular weight fraction (LMW) of phenolic compounds. Three
milliliter of hydrophobic fraction was loaded onto 40 mL LH-20
column, which has been conditioned by washing with 200 mL
of 30% methanol. The column was washed with 600 mL 30%
methanol to recover low molecular weight phenolic compounds
(LMW) and with 100 mL of acetone: deionized water: acetic acid
(70:29.9:0.01) (v/v/v) to collect the high molecular weight phenolic
compounds (HMW). A total of 20 mL of HBBT was subjected to
LH-20 extraction in portions of 2 and 3 mL and finally both frac-
tions were roto-evaporated by vacuum rotor evaporator (Fisher
Scientific; Hanover Park, IL, USA) to 20 mL to remove solvents
and stored at 4°C until further testing.
TOTAL PHENOLIC CONTENT DETERMINATION
The phenolic content of all extracts was determined by an assay
modified from Shetty et al. (13). Briefly, 0.5 mL of sample or stan-
dard was mixed with 0.5 mL distilled water, 1 mL 95% ethanol,
5 mL distilled water, and 0.5 mL 50% (v/v) Folin–Ciocalteu reagent
in test tubes. Then the test tubes were incubated at room temper-
ature for 5 min. After adding of 1 mL of 5% Na2CO3, the mix-
tures were kept in the dark at room temperature for 60 min. The
absorbance was measured at 725 nm (U 2001 Spectrophotometer;
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Hitachi, Pleasanton, CA, USA) after vortexing. Gallic acid stan-
dards were prepared (15.625, 31.25, 62.5, 125, 250, and 500µg/mL
in ethanol) and used to establish the standard curve. Results
were expressed as mg of gallic acid equivalents per gram of
sample (DW).
ANTIOXIDANT ACTIVITY BY 1,1-DIPHENYL-2-PICRYLHYDRAZYL
RADICAL INHIBITION ASSAY
The antioxidant activity by 1,1-Diphenyl-2-picrylhydrazyl
(DPPH) free-radical scavenging inhibition was determined fol-
lowing the procedure modified from Shetty et al. (13). The
percentage antioxidant activity (AA%) was determined in a dose-
dependent manner. Stock DPPH solution was prepared by adding
39 mg DPPH in 100 mL 95% ethanol. To 1 mL of DPPH solution
200µL of each extract was added and the decrease in absorbance
was monitored at 517 nm, using a spectrophotometer (U 2001
Spectrophotometer; Hitachi, Pleasanton, CA, USA) until a con-
stant reading was obtained. The readings were compared with the
controls, which contained 200µL of water instead of the extract.
The % inhibition was calculated by:
% inhibition =
(
Abscontrol − Abssample
Abscontrol
)
× 100
YEAST-α-GLUCOSIDASE INHIBITION ASSAY
The dose-dependent yeast α-glucosidase inhibitory activity was
determined in all whole extracts and recovered hydrophilic and
hydrophobic fractions after C18 extraction. A mixture of 50µL
extract and 100µL of 0.1 M phosphate buffer (pH 6.9) contain-
ing α-glucosidase solution (1.0 U/mL) were incubated in 96 well
plates at 25°C for 10 min. After pre-incubation, 50µL of 5 mM
p-nitrophenyl-α-d-glucopyranoside solution in 0.1 M phosphate
buffer (pH 6.9) was added to each well at timed intervals. The
reaction mixtures were incubated at 25°C for 5 min. Before and
after incubation, absorbance was recorded at 405 nm by micro-
plate reader (VMax, Molecular Device Co., Sunnyvale, CA, USA)
and compared to that of the control, which had 50µL buffer
solution in place of the extract. The α-glucosidase inhibitory
activity was expressed as inhibition % and was calculated as
followed:
% inhibition =
(
∆Abscontrol −∆Abssample
∆Abscontrol
)
× 100
PORCINE α-AMYLASE INHIBITION ASSAY
The dose-dependent α-amylase inhibitory activity of water
extracts was evaluated. A mixture of 500µL extract and 500µL
0.02 M sodium phosphate buffer (pH 6.9 with 0.006 M sodium
chloride) containing α-amylase solution (13 U/mL) was incubated
at 25°C for 10 min. After pre-incubation, 500µL of 1% soluble
starch solution in 0.02 M sodium phosphate buffer (pH 6.9 with
0.006 M NaCl) was added to each tube at timed intervals. The reac-
tion mixtures were then incubated at 25°C for 10 min followed by
addition of 1 mL dinitrosalicylic acid color reagent (14). The test
tubes were then placed in a boiling water bath for 5 min to stop the
reaction and cooled to room temperature. The reaction mixture
was then diluted with 10 mL of distilled water and the absorbance
was read at 540 nm. The % inhibitory activity was determined
using the following equation:
% inhibition =
(
∆Abscontrol −∆Abssample
∆Abscontrol
)
× 100
PHENOLIC PROFILE DETERMINATION WITH HPLC
The obtained HBBT, HMW, and LMW fractions were subjected
to HPLC to identify the differences in their phenolic profile. All
tested samples were concentrated by rotary evaporation (Fisher
Scientific; Hanover Park, IL, USA) to complete dryness and were
re-dissolved in 1 mL of acetone. To 800µL of each sample we
added 400µL of distilled water and the resulting solutions were fil-
tered using a 0.45µm Fisherbrand® syringe filter (Thermo Fisher
Sci, Pittsburg, PA, USA). An injection volume of 20µL of each
sample was injected and analyzed using a reverse phase C-18 col-
umn (Agilent ZORBAX Extend C-18 column, 250× 4.6 mm id.d,
5µm particle size). The mobile phase consisted of solvent A (4%
phosphoric acid) and solvent B (acetonitrile). Gradient elution
was used under linear gradient conditions starting with 95% A
and decreasing linearly to 65% A over a 70 minute time period
at a flow rate of 0.75 mL/min. Phenolic profiles were observed at
254 nm and 280 nm using a UV-VIS detector.
STATISTICAL ANALYSIS
All experiments were performed at least three times in triplicates.
Analysis at every time point from each experiment was carried out
in triplicates. Means, standard errors, standard deviations, and
IC50 values were calculated using Microsoft Excel XP.
RESULTS
TOTAL PHENOLIC CONTENT
The total phenolic content analyzed by Folin–Ciocalteau’s method
indicated that WBT had a phenolic content of 5.77 mg/mL
(Figure 1). As expected the total phenolic content of HBBT
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FIGURE 1 |Total phenolic content of black tea water extract fractions
and black tea pomace.
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was higher than the total phenolic content of HPBT (4.4 and
0.52 mg/mL, respectively) (Figure 1). After LH-20 extraction of
HBBT fraction the total phenolic content of HMW and LMW were
determined to be 2.66 and 1.43 mg/mL, respectively (Figure 1).
The WBT fraction had the highest phenolic content followed
by the HBBT fraction, which resulted after the C18 extraction. The
HBBT fraction was further subjected to LH-20 column separation
resulting in HMW and LMW fraction. HMW fraction had higher
phenolic content and the sum of both HMW and LMW pheno-
lic contents was similar to the HBBT phenolic content, suggesting
a successful recovery of phenolic phytochemicals following LH-
20 extraction. This shows that all phenolic compounds initially
present in the HBBT fraction were eluted either in methanol or in
acetone.
The phenolic content of pomace acetone extract (AOBT) was
8.63 mg/mL (Figure 1), suggesting that black tea pomace resulting
from hot water black tea extraction contains significant amount
of phenolic compounds that cannot be extracted using water as an
extraction medium.
ANTIOXIDANT ACTIVITY BY DPPH RADICAL INHIBITION ASSAY
The antioxidant activity in terms of DPPH free-radical scavenging
potential was evaluated for WBT, HBBT, and HPBT (Figure 2).
All tested samples had antioxidant activity in a dose-dependent
manner in the tested doses. More specifically, WBT fraction had
the highest antioxidant activity with 95.4% radical inhibition
(50× dilution) followed by HBBT (86.2% at the same dilution)
(Figure 2). HPBT fractions had the lowest antioxidant activity
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FIGURE 2 | Antioxidant activity of black tea water extract fractions and
black tea pomace.
(30.9% at the same dilution) (Figure 2). When the black tea
pomace acetone extract (AOBT) was evaluated we determined
that it had the highest antioxidant activity (100% at 50× dilution)
(Figure 2).
It is well documented that phenolic phytochemicals are effec-
tive antioxidants (6, 15–18) and our findings indicate that the
antioxidant activities are in agreement with the phenolic contents
(Figures 1 and 2).
α-GLUCOSIDASE INHIBITION ASSAY
The dose-dependent α-glucosidase inhibitory activities of WBT,
HBBT, HPBT, LMW, HMW, and AOBT were investigated. For
comparison, the results were expressed in IC50 values based on the
phenolic content (the phenolic concentration of extracts resulting
in 50% inhibition of enzyme activity). We observed that the HMW
fraction appeared to be the most bioactive fraction (IC50 8.97µg
phenolics/mL), followed by the HBBT fraction, with an IC50 of
14.8µg phenolics/mL (Table 1). The IC50 of the WBT and LMW
fractions were calculated to be 22.4 and 34.2µg phenolics/mL,
respectively, followed by HPBT (IC50: 503µg/mL), which had the
lowest inhibitory activity (Table 1).
Our observations clearly suggest that the most bioactive com-
ponents in black tea for α-glucosidase inhibition are high molec-
ular weight phenolic compounds. Our observations are in agree-
ment with our preliminary observations that the α-glucosidase
inhibitory activity increases as tea is fermented (6). During
fermentation low molecular weight catechins are polymerized
to form higher molecular weight teaflavin-3-3′-digallate and
thearubigin, which are catechin polymerization products (10).
When the α-glucosidase inhibitory activity of AOBT was eval-
uated we observed an IC50 14.7µg phenolics/mL (Table 1). This
inhibitory activity is lower than HBBT and HMW than the whole
black tea water extract (WBT). Our findings suggest that the
black tea pomace contains hydrophobic compounds that are not
extracted during hot water extraction, which have significant
potential for type 2 diabetes prevention via inhibition of carbo-
hydrate hydrolyzing enzymes. We suspect that these compounds
are hydrophobic in nature and most probably higher molecular
weight catechin polymerization products.
α-AMYLASE INHIBITION ASSAY
Similarly to the α-glucosidase inhibitory activities, the IC50 val-
ues of the α-amylase inhibitory activities were estimated for all
samples (Table 2). The IC50 of the WBT fraction was 1.74 mg
phenolics/mL, while the inhibitory activity of the HBBT fraction
was the most bioactive of all the tested fractions with an IC50
of 0.049 mg phenolics/mL. The HPBT fraction had a negligible
IC50 (131 mg phenolics/mL), while the IC50 of the HMW fraction
was calculated to be 0.42 mg phenolics/mL. Finally, AOBT extract
resulted to an IC50 value of 0.21 mg phenolics/mL.
Table 1 |Yeast α-glucosidase inhibition IC50 values based on total
phenolic content.
WBT HBBT HPBT LMW HMW AOBT
IC50 (µg/mL) 22.4 14.8 502 34.2 8.97 14.7
Frontiers in Nutrition | Food Chemistry February 2015 | Volume 2 | Article 3 | 4
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Striegel et al. Black tea pre-diabetes management
Table 2 | α-Amylase inhibition IC50 values based on total phenolic
content.
WBT HBBT HPBT LMW HMW AOBT
IC50 (mg/mL) 1.74 0.049 131 – 0.42 0.21
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FIGURE 3 | HPLC chromatogram of HBBT, HMW, and LMW at 280nm.
After comparing the resulting α-glucosidase and α-amylase
IC50 values the α-amylase inhibitory activity of the testes samples
was lower than the α-glucosidase inhibitory activity (Tables 1 and
2). The main side effects of type 2 diabetes control drugs, such
as acarbose, are abdominal distention, flatulence, meteorism, and
possibly diarrhea (19). It has been suggested that such adverse
effects might be caused by the excessive inhibition of pancre-
atic α-amylase resulting in the abnormal bacterial fermentation of
undigested carbohydrates in the colon (19). In our study, although
we observed a low α-amylase inhibitory activity, the possibility
of reduced side effects linked to excessive inhibition of starch
digestion is suggested.
PHENOLIC PROFILE DETERMINATION WITH HPLC
To confirm the successful fractionation using LH-20 extraction,
the phenolic profiles of HBBT, LMW, and HMW were determined
at 254 and 280 nm as described in the Section “Materials and
Methods” (Figures 3 and 4). Our observations suggest a differ-
ent phenolic profile in the three tested samples. The HBBT and
LMW fraction showed two peaks after 15.6 and 16.7 min with
λmax at 280 nm (Figure 3). These peaks were absent in the HMW
fraction. Additionally, at 34.7, 35.8, and 36.8 min the HBBT and
LMW fractions showed peaks with λmax at 254 nm (Figure 4).
There were also peaks at 39.7 and 42.1 min with a λmax at 254 nm
found in the HBBT and LMW fractions (Figure 4). These find-
ings suggest that these peaks are possibly low molecular weight
phenolic compounds. We were also able to identify unique peaks
found only in the HBBT and HMW fraction. We noticed that the
HMW chromatogram was slightly shifted, when compared to the
HBBT. In the HBBT fraction, two peaks were identified at 25.0
and 25.8 min. The same peaks could be identified in the HMW
fraction after 28.6 and 28.9 min. Additionally, in HBBT a peak was
identified at 37.7 min and this peak was also detected in the HMW
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FIGURE 4 | HPLC chromatogram of HBBT, HMW, and LMW at 254nm.
fraction at 39.2 min. Both peaks had a λmax at 280 nm (Figure 3).
Furthermore, three more peaks were identified to be unique for
the HBBT and HMW fraction. These compounds eluted at 47.4,
58.7, and 70.0 min and had a λmax at 280 nm (Figure 3) and could
not be identified in the LMW fraction.
Our results suggest that LH-20 extraction of HBBT using
two different solvents yielded two different fractions (LMW and
HMW) that have different phenolic profile. Although no com-
pounds were characterized in this research, we suspect that the
peaks appearing in both HBBT and HMW are high molecular
weight catechin polymerization products. More research is under-
way to effectively characterize the resulting HMW fraction and link
the identified compounds with specific carbohydrate hydrolyzing
enzyme inhibitory activity.
CONCLUSION
Type 2 diabetes is an emerging health concern in many parts of
the world. It is projected that diabetes will increase dramatically
during the next years and will be the 7th leading cause of death in
2030, mainly due to the increase in the incidence of type 2 diabetes
(1, 2).
It is well documented that phenolic phytochemicals have α-
glucosidase inhibitory activity that depends on the phenolic profile
(6, 17, 20). A recent study reported that cinnamon extract has
α-glucosidase inhibitory activity, which is low molecular weight
phenolic dependent (20). Another study in our lab showed that
the α-glucosidase inhibitory activity of blueberries is low mole-
cular weight phenolic dependent (21). In the case of blueberries
and cinnamon, the predominant high molecular weight phenolic
compounds are proanthocyanidins.
In this preliminary work, we identified that both black tea water
extract and black tea pomace have potential for type 2 diabetes
prevention, via inhibition of carbohydrate hydrolyzing enzymes,
namely α-glucosidase. The same extracts have a low α-amylase
inhibitory activity. Strong inhibition of α-glucosidase and low
inhibition of α-amylase could be potentially used as an effective
complementary therapy for postprandial hyperglycemia linked to
type 2 diabetes with reduced side effects. Our fractionation results,
coupled with the high bioactivity of the black tea pomace, suggest
that the observed effects are probably due to high molecular weight
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phenolics present in black tea, namely catechin polymerization
products. This conclusion is further supported from our previ-
ous findings (6) that suggest that α-glucosidase inhibition in tea
increases during fermentation. Further investigation is underway
to identify the specific high molecular weight phenolic compounds
in black tea and pomace of water extraction that are relevant to
the inhibition of carbohydrate hydrolysis enzymes.
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